Literature DB >> 20590660

Curcumin disrupts meiotic and mitotic divisions via spindle impairment and inhibition of CDK1 activity.

A Bielak-Zmijewska1, M Sikora-Polaczek, K Nieznanski, G Mosieniak, A Kolano, M Maleszewski, J Styrna, E Sikora.   

Abstract

OBJECTIVES: Curcumin, a natural compound, is a potent anti-cancer agent, which inhibits cell division and/or induces cell death. It is believed that normal cells are less sensitive to curcumin than malignant cells; however, the mechanism(s) responsible for curcumin's effect on normal cells are poorly understood. The aim of this study was to verify the hypothesis that curcumin affects normal cell division by influencing microtubule stability, using mouse oocyte and early embryo model systems.
MATERIALS AND METHODS: Maturating mouse oocytes and two-cell embryos were treated with different concentrations of curcumin (10-50 microm), and meiotic resumption and mitotic cleavage were analysed. Spindle and chromatin structure were visualized using confocal microscopy. In addition, acetylation and in vitro polymerization of tubulin, in the presence of curcumin, were investigated and the damage to double-stranded DNA was studied using gammaH2A.X. CDK1 activity was measured. RESULTS AND
CONCLUSIONS: We have shown for the first time, that curcumin, in a dose-dependent manner, delays and partially inhibits meiotic resumption of oocytes and inhibits meiotic and mitotic divisions by causing disruption of spindle structure and does not induce DNA damage. Our analysis indicated that curcumin affects CDK1 kinase activity but does not directly affect microtubule polymerization and tubulin acetylation. As our study showed that curcumin impairs generative and somatic cell division, its future clinical use or of its derivatives with improved bioavailability after oral administration, should take into consideration the possibility of extensive side-effects on normal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590660      PMCID: PMC6496310          DOI: 10.1111/j.1365-2184.2010.00684.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  62 in total

Review 1.  The tubulin code.

Authors:  Kristen J Verhey; Jacek Gaertig
Journal:  Cell Cycle       Date:  2007-06-26       Impact factor: 4.534

2.  Direct interaction between prion protein and tubulin.

Authors:  Krzysztof Nieznanski; Hanna Nieznanska; Krzysztof J Skowronek; Katarzyna M Osiecka; Dariusz Stepkowski
Journal:  Biochem Biophys Res Commun       Date:  2005-08-26       Impact factor: 3.575

3.  A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells.

Authors:  K Piwocka; K Zabłocki; M R Wieckowski; J Skierski; I Feiga; J Szopa; N Drela; L Wojtczak; E Sikora
Journal:  Exp Cell Res       Date:  1999-06-15       Impact factor: 3.905

4.  Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.

Authors:  Dinesh Ranjan; Changguo Chen; Thomas D Johnston; Hoonbae Jeon; Moolky Nagabhushan
Journal:  J Surg Res       Date:  2004-10       Impact factor: 2.192

5.  Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.

Authors:  Ebba U Kurz; Pauline Douglas; Susan P Lees-Miller
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

6.  Effects of organic acids on tubulin polymerization and associated guanosine 5'-triphosphate hydrolysis.

Authors:  E Hamel; A A del Campo; M C Lowe; P G Waxman; C M Lin
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

7.  EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1.

Authors:  Shala L Thomas; Diansheng Zhong; Wei Zhou; Sanna Malik; Dennis Liotta; James P Snyder; Ernest Hamel; Paraskevi Giannakakou
Journal:  Cell Cycle       Date:  2008-06-09       Impact factor: 4.534

Review 8.  Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.

Authors:  Alexios S Strimpakos; Ricky A Sharma
Journal:  Antioxid Redox Signal       Date:  2008-03       Impact factor: 8.401

9.  P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells.

Authors:  Anna Bielak-Mijewska; Katarzyna Piwocka; Adriana Magalska; Ewa Sikora
Journal:  Cancer Chemother Pharmacol       Date:  2003-10-03       Impact factor: 3.333

10.  Curcumin in cell death processes: a challenge for CAM of age-related pathologies.

Authors:  S Salvioli; E Sikora; E L Cooper; C Franceschi
Journal:  Evid Based Complement Alternat Med       Date:  2007-04-23       Impact factor: 2.629

View more
  5 in total

1.  Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation.

Authors:  Wolfgang W Quitschke
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

2.  Curcumin induces senescence of primary human cells building the vasculature in a DNA damage and ATM-independent manner.

Authors:  Wioleta Grabowska; Karolina Kucharewicz; Maciej Wnuk; Anna Lewinska; Małgorzata Suszek; Dorota Przybylska; Grazyna Mosieniak; Ewa Sikora; Anna Bielak-Zmijewska
Journal:  Age (Dordr)       Date:  2015-02-04

Review 3.  Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

Authors:  Avudaiappan Maran; Michael J Yaszemski; Ananiy Kohut; Andriy Voronov
Journal:  Materials (Basel)       Date:  2016-06-27       Impact factor: 3.623

4.  Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.

Authors:  S Belluti; V Basile; P Benatti; E Ferrari; G Marverti; C Imbriano
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

5.  Side Effects of Curcumin: Epigenetic and Antiproliferative Implications for Normal Dermal Fibroblast and Breast Cancer Cells.

Authors:  Laura Cianfruglia; Cristina Minnelli; Emiliano Laudadio; Andrea Scirè; Tatiana Armeni
Journal:  Antioxidants (Basel)       Date:  2019-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.